| 2922.31.00 | 00 | Amfepramone (INN), methadone (INN) and normethadone (INN); salts thereof | kg | Free | | 15.4￠/kg + 50% |
| 2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
| 2926.30.10 | 00 | Fenproporex (INN) and its salts | kg | Free | | 15.4￠/kg + 65.5% |
| 2933.19.15 | 00 | 1,2-Dimethyl-3,5-diphenyl-1H-pyrazolium methyl sulfate (Difenzoquat methyl sulfate) | kg | Free | | 15.4￠/kg + 48.5% |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.59.22 | 00 | Anti-infective agents: | | | | |
| 2933.99.06 | 00 | α-Butyl- α-(4-chlorophenyl)-1H-1,2,4- triazole-1- propanenitrile (Myclobutanil); and α-[2-(4-Chlorophenyl)ethyl]- α-phenyl-1H- 1,2,4-triazole-1-propanenitrile (Fenbuconazole) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 64.5% |
| 2933.99.42 | 00 | Anti-infective agents: | | | | |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2934.20.05 | 00 | N-tert-Butyl-2-benzothiazolesulfenamide | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 52% |
| 2934.20.15 | 00 | 2-Mercaptobenzothiazole; and N-(Oxydiethylene)benzothiazole-2-sulfenamide | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 52% |
| 2934.20.25 | 00 | 2-Amino-5,6-dichlorobenzothiazole; 2-(4-Aminophenyl)-6-methylbenzothiazole-7- sulfonic acid; 2-Amino-6-nitrobenzothiazole; and N,N-Dicyclohexyl-2-benzothiazolesulfenamide | kg | Free | | 15.4￠/kg + 52% |
| 2934.91.00 | 00 | Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof | kg | Free | | 15.4￠/kg + 52% |
| 2934.99.01 | 00 | Mycophenolate mofetil | kg | Free | | 15.4￠/kg + 45% |
| 2934.99.07 | 00 | Ethyl 2-[4-[(6-chloro-2-benzoxazolyl)oxy]- phenoxy]propanoate (Fenoxaprop-ethyl) | kg | Free | | 15.4￠/kg + 48.5% |
| 2935.00.13 | 00 | (5-[2-Chloro-4-(trifluoromethyl)phenoxy]-￠/(methylsulfonyl)-2-nitrobenzamide) (Fomesafen); N-(2,6-Dichloro-3-methylphenyl)-5-amino-1,3,4- triazole-2-sulfonamide; 2,4-Dichloro-5-sulfamoylbenzoic acid; N-Ethyl-o-toluenesulfonamide; N-Ethyl-p-toluenesulfonamide; 7-(Hexadecylsulfonylamino)-1H-indole; Methyl 5-{[(4,6-dimethoxy-2-pyrimidinyl)amino]- carbonylaminosulfonyl}-3-chloro-1-methyl-1H- pyrazole-4-carboxylate (Halosulfuron methyl); and Mixtures of ortho- and para-toluene sulfonamides | kg | Free | | 15.4￠/kg + 57.5% |
| 2935.00.29 | 00 | Anti-infective agents: | | | | |
| 2939.30.00 | 00 | Caffeine and its salts | kg | Free | | 59% |
| 2939.51.00 | 00 | Fenetylline (INN) and its salts | kg | Free | | 25% |
| 2939.91.00 | 00 | Cocaine, ecgonine, levometamfetamine, metamfetamine (INN), metamfetamine racemate; salts, esters and other derivatives thereof | kg | Free | | 25% |
| 2941.10.30 | 00 | Carfecillin, sodium; Cloxacillin, sodium; Dicloxacillin, sodium; Flucloxacillin (Floxacillin); and Oxacillin, sodium | kg | Free | | 15.4￠/kg + 45% |
| 3002.10.01 | 40 | Fetal Bovine Serum (FBS) | kg | | | |
| 3002.90.10 | 00 | Ferments | kg | Free | | 25% |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
